A "gene silencer" (technically known as small interfering RNA, or siRNA), locally delivered by nanoparticles embedded in an ...
More than 3.5 billion years ago, the Earth was not the hospitable world we know today. The atmosphere lacked oxygen, the seas ...
In the quiet woods of West Bengal and the lush countryside of Kerala, a lethal pathogen is once again testing the limits of ...
In this second of three articles on The Sunday Times top 100 tech companies list, pharmaphorum is focusing on the first nine ...
Agrace, a leading nonprofit provider of hospice care, palliative care, and dementia care services, today announced plans to build the Ellen & Peter Johnson Dementia Village at Agrace, the first ...
2don MSN
Fecal transplant capsules show promising results in clinical trials for multiple types of cancer
Fecal microbiota transplants (FMT) can dramatically improve cancer treatment, suggest two groundbreaking studies published in ...
An estimated 3 million Americans have an inflammatory bowel disease (IBD) such as Crohn's disease or ulcerative colitis. But ...
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer .
Cancer evolves through layers of change: mutations in DNA, shifts in gene regulation, altered cell behaviour, and dynamic ...
Delve into what 2026 has to offer in the biotech industry. The market is showing signs it's picking up and the patent cliff ...
The global skin-lightening market is worth over $10 billion and growing, but the unregulated products driving it contain ...
Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results